Cargando…
Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767990/ https://www.ncbi.nlm.nih.gov/pubmed/36459337 http://dx.doi.org/10.1007/s11864-022-01038-z |
| _version_ | 1784854076354199552 |
|---|---|
| author | Zhong, Jingqin Yan, Wangjun Wang, Chunmeng Liu, Wanlin Lin, Xinyi Zou, Zijian Sun, Wei Chen, Yong |
| author_facet | Zhong, Jingqin Yan, Wangjun Wang, Chunmeng Liu, Wanlin Lin, Xinyi Zou, Zijian Sun, Wei Chen, Yong |
| author_sort | Zhong, Jingqin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9767990 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97679902022-12-22 Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies Zhong, Jingqin Yan, Wangjun Wang, Chunmeng Liu, Wanlin Lin, Xinyi Zou, Zijian Sun, Wei Chen, Yong Curr Treat Options Oncol Correction Springer US 2022-12-02 2022 /pmc/articles/PMC9767990/ /pubmed/36459337 http://dx.doi.org/10.1007/s11864-022-01038-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Zhong, Jingqin Yan, Wangjun Wang, Chunmeng Liu, Wanlin Lin, Xinyi Zou, Zijian Sun, Wei Chen, Yong Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title | Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title_full | Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title_fullStr | Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title_full_unstemmed | Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title_short | Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies |
| title_sort | correction to: braf inhibitor resistance in meslanoma: mechanisms and alternative therapeutic strategies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767990/ https://www.ncbi.nlm.nih.gov/pubmed/36459337 http://dx.doi.org/10.1007/s11864-022-01038-z |
| work_keys_str_mv | AT zhongjingqin correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT yanwangjun correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT wangchunmeng correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT liuwanlin correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT linxinyi correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT zouzijian correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT sunwei correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies AT chenyong correctiontobrafinhibitorresistanceinmeslanomamechanismsandalternativetherapeuticstrategies |